Literature DB >> 8710066

Validation of the functional assessment of multiple sclerosis quality of life instrument.

D F Cella1, K Dineen, B Arnason, A Reder, K A Webster, G karabatsos, C Chang, S Lloyd, J Steward, D Stefoski.   

Abstract

Based on scientific literature and interviews with clinicians and patients, we developed a quality of life instrument for use with people with MS called the Functional Assessment of Multiple Sclerosis (FAMS). The initial item pool consisted of 88 questions: 28 from the general version of the Functional Assessment of Cancer Therapy quality of life instrument, plus 60 generated by patients, providers, and literature review. The validation samples comprised a mail survey cohort (N = 377) and a clinical cohort (N = 56). Both cohorts provides evidence for internal consistency of the derived subscales, test-retest reliability, content validity, concurrent validity, and construct validity. Principal components and Rasch measurement model analyses were applied sequentially to survey sample data, reducing test length to 44 questions, divided into six subscales: mobility, symptoms, emotional well-being (depression), general contentment, thinking/fatigue, and family/social well-being. Fifteen initially rejected questions were added back as miscellaneous (unscored) questions for their potential clinical and empirical value. The mobility subscale was strongly predictive of the Kurtzke Extended Disability Status Scale and the Scripps Neurologic Rating Scales. The other five subscales were not, indicating they measure aspects of patient quality of life not captured by the neurologic exam. The final 59-item English language instrument (FAMS version 2) is available for inclusion in clinical trials and clinical practice.

Entities:  

Mesh:

Year:  1996        PMID: 8710066     DOI: 10.1212/wnl.47.1.129

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  89 in total

Review 1.  Quality of life and neurological illness: a review of the literature.

Authors:  R Murrell
Journal:  Neuropsychol Rev       Date:  1999-12       Impact factor: 7.444

Review 2.  Fatigue in multiple sclerosis: definition, pathophysiology and treatment.

Authors:  Lauren B Krupp
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

3.  Quality of life improvement after videothoracoscopic splanchnicectomy in chronic pancreatitis patients: case control study.

Authors:  Wojciech Makarewicz; Tomasz Stefaniak; Marlena Kossakowska; Andrzej Basiński; Marek Suchorzewski; Aleksander Stanek; Zbigniew B Gruca
Journal:  World J Surg       Date:  2003-06-26       Impact factor: 3.352

4.  What sample sizes for reliability and validity studies in neurology?

Authors:  Jeremy C Hobart; Stefan J Cano; Thomas T Warner; Alan J Thompson
Journal:  J Neurol       Date:  2012-06-24       Impact factor: 4.849

5.  Reliability and validity of the Functional Assessment of Cancer Therapy General (FACT-G) in French cancer patients.

Authors:  Nathalie Costet; Valérie Lapierre; Ellen Benhamou; Catherine Le Galès
Journal:  Qual Life Res       Date:  2005-06       Impact factor: 4.147

Review 6.  Pharmacological treatment of early multiple sclerosis.

Authors:  Olaf Stüve; Jeffrey L Bennett; Bernhard Hemmer; Heinz Wiendl; Michael K Racke; Amit Bar-Or; Wei Hu; Robert Zivadinov; Martin S Weber; Scott S Zamvil; Maria F Pacheco; Til Menge; Hans-Peter Hartung; Bernd C Kieseier; Elliot M Frohman
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 7.  Secondary Progressive Multiple Sclerosis: Definition and Measurement.

Authors:  Domenico Plantone; Floriana De Angelis; Anisha Doshi; Jeremy Chataway
Journal:  CNS Drugs       Date:  2016-06       Impact factor: 5.749

8.  Monitoring my multiple sclerosis: a patient-administered health-assessment scale.

Authors:  Elsie E Gulick; Marie Namey; June Halper
Journal:  Int J MS Care       Date:  2011

9.  An RCT to treat learning impairment in multiple sclerosis: The MEMREHAB trial.

Authors:  Nancy D Chiaravalloti; Nancy B Moore; Olga M Nikelshpur; John DeLuca
Journal:  Neurology       Date:  2013-11-08       Impact factor: 9.910

Review 10.  The effect of deep brain stimulation on quality of life in movement disorders.

Authors:  A Diamond; J Jankovic
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.